IL6 and Atrophy/Degeneration affecting the brainstem: In CPNB patients, IFX has been reported to reduce CSF IL-6 concentrations and thereby inhibit the progression of CPNB.[15] In the present study as well, IFX lowered CSF IL-6 concentrations and resolved clinical symptoms in a CPNB patient without the occurrence of brainstem atrophy.